Skip to main contentSkip to navigation
Sirius Investors
Pear Therapeutics, Inc.

Pear Therapeutics, Inc.

PEAR
NASDAQHealthcare

Revenue Analysis - PEAR

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

PEAR Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Product

0.0% of total revenue

$1.1M

Collaboration And License Revenue

0.0% of total revenue

$17.0K

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 4 records)

Date
Collaboration And License Revenue
Product
12/31/2022$17.0K$1.1M
9/30/2022$555.0K$3.5M
6/30/2022$300.0K$3.0M
3/31/2022$0$2.7M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Declining Segments
Collaboration And License Revenue-96.9%
Product-67.6%

Earnings Reports

Want to see how PEAR's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports